290 related articles for article (PubMed ID: 38540673)
1. Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.
Fu Y; Zhang Z; Webster KA; Paulus YM
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540673
[TBL] [Abstract][Full Text] [Related]
2. Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization.
Zhang Z; Shen MM; Fu Y
Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):2. PubMed ID: 36318195
[TBL] [Abstract][Full Text] [Related]
3. Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities.
Mettu PS; Allingham MJ; Cousins SW
Prog Retin Eye Res; 2021 May; 82():100906. PubMed ID: 33022379
[TBL] [Abstract][Full Text] [Related]
4. Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review.
Yang S; Zhao J; Sun X
Drug Des Devel Ther; 2016; 10():1857-67. PubMed ID: 27330279
[TBL] [Abstract][Full Text] [Related]
5. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
6. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
Emerson MV; Lauer AK
BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
8. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
Feng L; Hu JH; Chen J; Xie X
J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
[TBL] [Abstract][Full Text] [Related]
9. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
Lu X; Sun X
Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
[TBL] [Abstract][Full Text] [Related]
10. The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.
Teo KYC; Gillies M; Fraser-Bell S
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177632
[TBL] [Abstract][Full Text] [Related]
11. Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice.
Zhu L; Parker M; Enemchukwu N; Shen M; Zhang G; Yan Q; Handa JT; Fang L; Fu Y
Commun Biol; 2020 Jul; 3(1):386. PubMed ID: 32678293
[TBL] [Abstract][Full Text] [Related]
12. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
Steinle NC; Du W; Gibson A; Saroj N
Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
[TBL] [Abstract][Full Text] [Related]
13. Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy.
Yang S; Li T; Jia H; Gao M; Li Y; Wan X; Huang Z; Li M; Zhai Y; Li X; Yang X; Wang T; Liang J; Gu Q; Luo X; Qian L; Lu S; Liu J; Song Y; Wang F; Sun X; Yu D
Sci Transl Med; 2022 Jun; 14(647):eabj2177. PubMed ID: 35648811
[TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
15. Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration.
Wu J; Zhang J
Front Biosci (Landmark Ed); 2022 Apr; 27(4):135. PubMed ID: 35468694
[TBL] [Abstract][Full Text] [Related]
16. Aflibercept for neovascular age-related macular degeneration.
Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
Song JH; Moon KY; Lee SC; Kim SS
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
[TBL] [Abstract][Full Text] [Related]
18. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
Du H; Sun X; Guma M; Luo J; Ouyang H; Zhang X; Zeng J; Quach J; Nguyen DH; Shaw PX; Karin M; Zhang K
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2377-82. PubMed ID: 23341606
[TBL] [Abstract][Full Text] [Related]
19. Neovascular age-related macular degeneration: potential therapies.
Chappelow AV; Kaiser PK
Drugs; 2008; 68(8):1029-36. PubMed ID: 18484796
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.
Zhao M; Mantel I; Gelize E; Li X; Xie X; Arboleda A; Seminel M; Levy-Boukris R; Dernigoghossian M; Prunotto A; Andrieu-Soler C; Rivolta C; Canonica J; Naud MC; Lechner S; Farman N; Bravo-Osuna I; Herrero-Vanrell R; Jaisser F; Behar-Cohen F
Nat Commun; 2019 Jan; 10(1):369. PubMed ID: 30664640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
